1
|
Luo Z, Ye C, Xiao H, Yin J, Liang Y, Ruan Z, Luo D, Gao D, Tan Q, Li Y, Zhang Q, Liu W, Wu J. Optimization of loop-mediated isothermal amplification (LAMP) assay for robust visualization in SARS-CoV-2 and emerging variants diagnosis. Chem Eng Sci 2022; 251:117430. [PMID: 35043022 PMCID: PMC8757654 DOI: 10.1016/j.ces.2022.117430] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2021] [Revised: 12/28/2021] [Accepted: 01/07/2022] [Indexed: 11/24/2022]
Abstract
Loop-mediated isothermal amplification (LAMP) is widely used in detection of pathogenic microorganisms including SARS-CoV-2. However, the performance of LAMP assay needs further exploration in the emerging SARS-CoV-2 variants test. Here, we design serials of primers and select an optimal set for LAMP-based on SARS-CoV-2 N gene for a robust and visual assay in SARS-CoV-2 diagnosis. The limit of detectable template reaches 10 copies of N gene per 25 μL reaction at isothermal 58℃ within 40 min. Importantly, the primers for LAMP assay locate at 12 to 213 nt of N gene, a highly conservative region, which serves as a compatible test in emerging SARS-CoV-2 variants. Comparison to a commercial qPCR assay, this LAMP assay exerts the high viability in diagnosis of 41 clinical samples. Our study optimizes an advantageous LAMP assay for colorimetric detection of SARS-CoV-2 and emerging variants, which is hopeful to be a promising test in COVID-19 surveillance.
Collapse
Key Words
- COVID-19, coronavirus disease 2019
- CRISPR, clustered regularly interspaced short palindromic repeats
- Coronavirus disease 2019 (COVID-19) pandemic
- Ct, threshold cycle
- Emerging SARS-CoV-2 variants
- IVD, in-vitro diagnosis
- LAMP, Loop-mediated isothermal amplification
- Loop-mediated isothermal amplification (LAMP)
- NGS, next-generation sequencing
- POC, point-of-care
- RT-qPCR, real-time reverse transcriptase quantitative polymerase chain reaction
- SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnosis
- VOC, variants of concern
Collapse
Affiliation(s)
- Zhen Luo
- Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China.,Foshan Institute of Medical Microbiology, Foshan 528315, China
| | - Chunhong Ye
- Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China
| | - Heng Xiao
- Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China.,Foshan Institute of Medical Microbiology, Foshan 528315, China
| | - Jialing Yin
- Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China
| | - Yicong Liang
- Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China
| | - Zhihui Ruan
- Foshan Institute of Medical Microbiology, Foshan 528315, China
| | - Danju Luo
- Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Daolong Gao
- Guangdong Longfan Biological Science and Technology Company, Shunde District, Foshan 528315, China
| | - Qiuping Tan
- Guangdong Longfan Biological Science and Technology Company, Shunde District, Foshan 528315, China
| | - Yongkui Li
- Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China.,Foshan Institute of Medical Microbiology, Foshan 528315, China
| | - Qiwei Zhang
- Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China.,Foshan Institute of Medical Microbiology, Foshan 528315, China
| | - Weiyong Liu
- Tongji Hospital of Huazhong University of Science and Technology, Wuhan 430030, China
| | - Jianguo Wu
- Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China.,Foshan Institute of Medical Microbiology, Foshan 528315, China.,Guangdong Longfan Biological Science and Technology Company, Shunde District, Foshan 528315, China
| |
Collapse
|
2
|
Zhang Y, Tanner NA. Improving RT-LAMP detection of SARS-CoV-2 RNA through primer set selection and combination. PLoS One 2022; 17:e0254324. [PMID: 35363770 PMCID: PMC8974972 DOI: 10.1371/journal.pone.0254324] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Accepted: 03/21/2022] [Indexed: 11/18/2022] Open
Abstract
Reverse transcription loop-mediated isothermal amplification (RT-LAMP) has emerged as a viable molecular diagnostic method to expand the breadth and reach of nucleic acid testing, particularly for SARS-CoV-2 detection and surveillance. While rapidly growing in prominence, RT-LAMP remains a relatively new method compared to the standard RT-qPCR, and contribution to our body of knowledge on designing LAMP primer sets and assays can have significant impact on its utility and adoption. Here we select and evaluate 18 LAMP primer sets for SARS-CoV-2 previously identified as sensitive ones under various conditions, comparing their speed and sensitivity with two LAMP formulations each with 2 reaction temperatures. We find that both LAMP formulations have some effects on the speed and detection sensitivity and identify several primer sets with similar high sensitivity for different SARS-CoV-2 gene targets. Significantly we observe a consistent sensitivity enhancement by combining primer sets for different targets, confirming and building on earlier work to create a simple, general approach to building better and more sensitive RT-LAMP assays.
Collapse
Affiliation(s)
- Yinhua Zhang
- Research Department, New England Biolabs, Ipswich, Massachusetts, United States of America
| | - Nathan A. Tanner
- Research Department, New England Biolabs, Ipswich, Massachusetts, United States of America
- * E-mail:
| |
Collapse
|